ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

281 - 300 out of 1,019 results.

SCIESCOPUS
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

Steensma, DP[Steensma, David P.]; Fenaux, P[Fenaux, Pierre]; Van Eygen, K[Van Eygen, Koen]; Raza, A[Raza, Azra]; Santini, V[Santini, Valeria]; Germing, U[Germing, Ulrich]; Font, P[Font, Patricia]; Diez-Campelo, M[Diez-Campelo, Maria]; Thepot, S[Thepot, Sylvain]; Vellenga, E[Vellenga, Edo], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.1, pp.48 - +PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

Kojima, T[Kojima, Takashi]; Shah, MIA[Shah, Manish A.]; Muro, K[Muro, Kei]; Francois, E[Francois, Eric]; Adenis, A[Adenis, Antoine]; Hsu, CH[Hsu, Chih-Hung]; Doi, T[Doi, Toshihiko]; Moriwaki, T[Moriwaki, Toshikazu]; Kim, SB[Kim, Sung-Bae]; Lee, SH[Lee, Se-Hoon], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.35, pp.4138 - 4148PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Camidge, D.R.[Camidge, D.R.]; Kim, H.R.[Kim, H.R.]; Ahn, M.-J.[Ahn, M.-J.]; Yang, J.C.H.[Yang, J.C.H.]; Han, J.-Y.[Han, J.-Y.]; Hochmair, M.J.[Hochmair, M.J.]; Lee, K.H.[Lee, K.H.]; Delmonte, A.[Delmonte, A.]; García, Campelo M.R.[García, Campelo M.R.]; Kim, D.-W.[Kim, D.-W.], et al.

ArticleIssue Date2020CitationJournal of Clinical Oncology, v.38, no.31, pp.3592 - 3603PublisherAmerican Society of Clinical Oncology
SCIESCOPUS
Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial

DiSilvestro, P[DiSilvestro, Paul]; Colombo, N[Colombo, Nicoletta]; Scambia, G[Scambia, Giovanni]; Kim, BG[Kim, Byoung-Gie]; Oaknin, A[Oaknin, Ana]; Friedlander, M[Friedlander, Michael]; Lisyanskaya, A[Lisyanskaya, Alla]; Floquet, A[Floquet, Anne]; Leary, A[Leary, Alexandra]; Sonke, GS[Sonke, Gabe S.], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.30, pp.3528 - +PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

Van Cutsem, E[Van Cutsem, Eric]; Tempero, MA[Tempero, Margaret A.]; Sigal, D[Sigal, Darren]; Oh, DY[Oh, Do-Youn]; Fazio, N[Fazio, Nicola]; Macarulla, T[Macarulla, Teresa]; Hitre, E[Hitre, Erika]; Hammel, P[Hammel, Pascal]; Hendifar, AE[Hendifar, Andrew E.]; Bates, SE[Bates, Susan E.], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.27, pp.3185 - +PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma

Catenacci, DVT[Catenacci, Daniel V. T.]; Rasco, D[Rasco, Drew]; Lee, J[Lee, Jeeyun]; Rha, SY[Rha, Sun Young]; Lee, KW[Lee, Keun-Wook]; Bang, YJ[Bang, Yung Jue]; Bendell, J[Bendell, Johanna]; Enzinger, P[Enzinger, Peter]; Marina, N[Marina, Neyssa]; Xiang, H[Xiang, Hong], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.21, pp.2418 - +PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after platinum-based first-line (1L) chemotherapy in advanced urothelial carcinoma (UC): JAVELIN Bladder 100 phase III interim analysis.

Powles, T[Powles, Thomas]; Park, SH[Park, Se Hoon]; Voog, E[Voog, Eric]; Caserta, C[Caserta, Claudia]; Valderrama, BP[Valderrama, B. P.]; Gurney, H[Gurney, Howard]; Kalofonos, H[Kalofonos, Haralabos]; Radulovic, S[Radulovic, Sinisa]; Demey, W[Demey, Wim]; Ullen, A[Ullen, Anders], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.18PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase III, open-label, randomized study of atezolizumab in combination with carboplatin plus paclitaxel plus bevacizumab compared with pemetrexed plus cisplatin or carboplatin with stage IV non-squamous non-small cell lung cancer (NSCLC) with activating EGFR mutation or ALK translocation (ATLAS Trial).

Park, S[Park, Sehhoon]; Lee, YG[Lee, Yun-Gyoo]; Park, JH[Park, Ji Hyun]; Lee, GW[Lee, Gyeong-Won]; Kang, EJ[Kang, Eun Joo]; Choi, YJ[Choi, Yoon Ji]; Shin, S[Shin, SeongHoon]; Han, JY[Han, Ji-Youn]; Lee, S[Lee, Suee]; Kim, Y[Kim, YuJung], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Novel target discovery in pembrolizumab-resistant gastric cancer using a comprehensive RNA-seq analysis pipeline.

Lee, J[Lee, Jeeyun]; Kim, ST[Kim, Seung Tae]; Kim, KM[Kim, Kyoung-Mee]; Schultz, E[Schultz, Eric]; Skrzypczak, S[Skrzypczak, Stan]; Patro, R[Patro, Rob]; Kingsford, C[Kingsford, Carl]

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer (TNBC) with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).

Park, IH[Park, In Hae]; Kim, GM[Kim, Gun Min]; Kim, JH[Kim, Jee Hyun]; Kim, H[Kim, Hanjo]; Park, KH[Park, Kyong Hwa]; Park, YH[Park, Yeon Hee]; Baek, SK[Baek, Sun Kyung]; Sim, SH[Sim, Sung Hoon]; Ahn, HK[Ahn, Hee Kyung]; Lee, GW[Lee, Gyeong-Won], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
ZW25, an anti-HER2 bispecific antibody, plus chemotherapy with/without tislelizumab as first-line treatment for patients with advanced HER2-positive breast cancer or gastric/gastroesophageal junction adenocarcinoma: A phase 1B/2 trial-in-progress.

Oh, Y[Oh, Youn]; Chung, HC[Chung, Hyun Cheol]; Im, YH[Im, Young Hyuck]; Yen, CJ[Yen, Chia Jui]; Chao, Y[Chao, Yee]; Li, ZZ[Li, ZheZhen]; Wang, X[Wang, Xin]; Wang, J[Wang, Jin]; Li, HY[Li, Huiyan]; Kang, YK[Kang, Yoon-Koo]

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Sequential treatment with sorafenib (SOR) followed by regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (HCC): Interim analysis of the observational REFINE study.

Merle, P[Merle, Philippe]; Lim, HY[Lim, Ho Yeong]; Finn, RS[Finn, Richard S.]; Ikeda, M[Ikeda, Masafumi]; Kudo, M[Kudo, Masatoshi]; Frenette, CT[Frenette, Catherine T.]; Masi, G[Masi, Gianluca]; Kim, YJ[Kim, Yoon Jun]; Gerolami, R[Gerolami, Rene]; Kurosaki, M[Kurosaki, Masayuki], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase II open-label, multicenter, study to evaluate the efficacy and safety of rivoceranib in subjects with recurrent or metastatic adenoid cystic carcinoma.

Kang, H[Kang, Hyunseok]; Ho, AL[Ho, Alan Loh]; Muzaffar, J[Muzaffar, Jameel]; Bowles, DW[Bowles, Daniel W.]; Kim, SB[Kim, Sung-Bae]; Ahn, MJ[Ahn, Myung-Ju]; Hanna, GJ[Hanna, Glenn J.]; Worden, FP[Worden, Francis P.]; Yun, T[Yun, Tak]; Norton, S[Norton, Steven], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Do we consider to apply the value framework of cancer drugs to clinical practice and health insurance coverage in Korea?

Kim, DY[Kim, Do Yeun]; Ha, H[Ha, Hyerim]; Lee, HY[Lee, Hee Yeon]; Koo, DH[Koo, Dong-Hoe]; Han, HS[Han, Hye Sook]; Jun Kim, H[Jun Kim, Hee]; Oh, SY[Oh, Sung Yong]; Bae, S[Bae, SeungJin]; Bae, G[Bae, Green]; Cho, JY[Cho, Jae-Young], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Similar negative emotional impact on hair loss in neoadjuvant endocrine therapy compared to neoadjuvant chemotherapy in young women with breast cancer from patient reported outcomes.

Gwark, SC[Gwark, Sung-chan]; Ahn, SH[Ahn, Sei Hyun]; Noh, WC[Noh, Woo Chul]; Lee, ES[Lee, Eun Sook]; Jung, Y[Jung, Yongsik]; Kim, LS[Kim, Lee Su]; Han, W[Han, Wonshik]; Nam, SJ[Nam, Seok Jin]; Gong, G[Gong, Gyungyub]; Kim, SO[Kim, Seon-Ok], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase III trial of capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer (CAPItello290).

Schmid, P[Schmid, Peter]; Cortes, J[Cortes, Javier]; Robson, ME[Robson, Mark E.]; Iwata, H[Iwata, Hiroji]; Hegg, R[Hegg, Roberto]; Nechaeva, M[Nechaeva, Marina]; Xu, BH[Xu, Binghe]; Verma, S[Verma, Sunil]; Haddad, V[Haddad, Vincent]; Imedio, ER[Imedio, Esteban Rodrigo], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
PD-L1 expression as a prognostic marker in patients with advanced biliary tract cancer.

Kim, H[Kim, Hyera]; Hong, JY[Hong, Jung Yong]; Lee, J[Lee, Jeeyun]; Park, SH[Park, Se Hoon]; Park, JO[Park, Joon Oh]; Park, YS[Park, Young Suk]; Lim, HY[Lim, Ho Yeong]; Kang, WK[Kang, Won Ki]; Kim, ST[Kim, Seung Tae]

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Intracranial activity of selpercatinib (LOXO-292) in RET fusion-positive non-small cell lung cancer (NSCLC) patients on the LIBRETTO-001 trial.

Subbiah, V[Subbiah, Vivek]; Gainor, JF[Gainor, Justin F.]; Oxnard, GR[Oxnard, Geoffrey R.]; Tan, DSW[Tan, Daniel Shao-Weng]; Owen, DH[Owen, Dwight Hall]; Cho, BC[Cho, Byoung Chul]; Loong, HHF[Loong, Herbert H. F.]; McCoach, CE[McCoach, Caroline Elizabeth]; Weiss, J[Weiss, Jared]; Kim, Y[Kim, YuJung], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Preliminary safety and efficacy of GX-17, a long-acting interleukin-7, in combination with pembrolizumab in patients with refractory or recurrent metastatic triple negative breast cancer (mTNBC): Dose escalation period of Phase Ib/II study (KEYNOTE-899).

Sohn, J[Sohn, Joohyuk]; Park, KH[Park, Kyong Hwa]; Ahn, HK[Ahn, Hee Kyung]; Lee, KS[Lee, Keun Seok]; Kim, JH[Kim, Jee Hyun]; Kim, SB[Kim, Sung-Bae]; Lee, KE[Lee, Kyoung Eun]; Kim, JH[Kim, Jee Hung]; Yang, SH[Yang, Se Hwan]; Le, NT[Le, Ngocdiep T.], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: A randomized, phase II, multicenter, open-label study (DESTINY-Gastric01).

Shitara, K[Shitara, Kohei]; Bang, YJ[Bang, Yung-Jue]; Iwasa, S[Iwasa, Satoru]; Sugimoto, N[Sugimoto, Naotoshi]; Ryu, MH[Ryu, Min-hee]; Sakai, D[Sakai, Daisuke]; Chung, HC[Chung, Hyun Cheol]; Kawakami, H[Kawakami, Hisato]; Yabusaki, H[Yabusaki, Hiroshi]; Lee, J[Lee, Jeeyun], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
first 11 12 13 14 15 16 17 18 19 20 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어